Health
Mouse-adapted SARS-CoV-2 model helps advance the development of COVID-19 vaccines – News-Medical.Net
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Reviewed by Emily Henderson, B.Sc.Aug 27 2020
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Researchers, among them virologists and microbiologists at UNC-Chapel Hill’s Gillings School of Global Public Health, describe the mouse-adapted SARS-CoV-2 model in a paper fast-tracked and published Aug. 27 in Nature.
Small animal models that r…
-
Noosa News23 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business17 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General22 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands